Fidelity Investments’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Buy |
326,420
+14,948
| +5% | +$69.8K | ﹤0.01% | 2579 |
|
|
2025
Q1 | $1.71M | Buy |
311,472
+263,698
| +552% | +$1.45M | ﹤0.01% | 2497 |
|
|
2024
Q4 | $162K | Buy |
47,774
+26,334
| +123% | +$89.3K | ﹤0.01% | 3354 |
|
|
2024
Q3 | $61.1K | Buy |
21,440
+407
| +2% | +$1.16K | ﹤0.01% | 3692 |
|
|
2024
Q2 | $47.3K | Buy |
21,033
+7,885
| +60% | +$17.7K | ﹤0.01% | 3641 |
|
|
2024
Q1 | $29.1K | Buy |
13,148
+677
| +5% | +$1.5K | ﹤0.01% | 3843 |
|
|
2023
Q4 | $29.3K | Buy |
12,471
+3,179
| +34% | +$7.47K | ﹤0.01% | 3756 |
|
|
2023
Q3 | $17.3K | Sell |
9,292
-52
| -0.6% | -$97 | ﹤0.01% | 3880 |
|
|
2023
Q2 | $24.5K | Buy |
9,344
+232
| +3% | +$608 | ﹤0.01% | 3755 |
|
|
2023
Q1 | $14.9K | Buy |
9,112
+5,897
| +183% | +$9.61K | ﹤0.01% | 3972 |
|
|
2022
Q4 | $4.28K | Buy |
3,215
+284
| +10% | +$378 | ﹤0.01% | 4306 |
|
|
2022
Q3 | $5K | Buy |
2,931
+2,084
| +246% | +$3.56K | ﹤0.01% | 4343 |
|
|
2022
Q2 | $1K | Buy |
847
+344
| +68% | +$406 | ﹤0.01% | 4818 |
|
|
2022
Q1 | $1K | Buy |
+503
| New | +$1K | ﹤0.01% | 4860 |
|
|
2020
Q2 | – | Sell |
-266,300
| Closed | -$519K | – | 4222 |
|
|
2020
Q1 | $519K | Buy |
+266,300
| New | +$519K | ﹤0.01% | 2421 |
|
|
2019
Q4 | – | Sell |
-4,048,102
| Closed | -$39.8M | – | 4315 |
|
|
2019
Q3 | $39.8M | Buy |
4,048,102
+668,389
| +20% | +$6.57M | ﹤0.01% | 1278 |
|
|
2019
Q2 | $38.7M | Buy |
3,379,713
+416,695
| +14% | +$4.77M | ﹤0.01% | 1342 |
|
|
2019
Q1 | $29.7M | Buy |
2,963,018
+682,050
| +30% | +$6.85M | ﹤0.01% | 1424 |
|
|
2018
Q4 | $38.8M | Buy |
2,280,968
+447,937
| +24% | +$7.61M | 0.01% | 1251 |
|
|
2018
Q3 | $32.2M | Buy |
1,833,031
+1,031,231
| +129% | +$18.1M | ﹤0.01% | 1488 |
|
|
2018
Q2 | $15.2M | Buy |
+801,800
| New | +$15.2M | ﹤0.01% | 1813 |
|